AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
AUDUBON, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. a leading musculoskeletal technology company, today announced that it completed the acquisition of Synaptive Medical, deepening the Company’s presence in cranial
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, today announced that Natalie Holles, CEO
Alamar’s NULISAseq™ Immune 340 and NULISAseq™ Neuro 220 panels will be used to investigate disease progression, biological subtypes and treatment response FREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Alamar Biosciences, Inc.
MIAMI, Nov. 03, 2026 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), the data and AI security leader, today announced financial results for the third quarter ended September 30, 2026. Financial Summary
Milwaukee, Wisconsin, Nov. 03, 2026 (GLOBE NEWSWIRE) — Weyco Group, Inc. (NASDAQ: WEYS) (the “Company”) announced that today its Board of Directors declared a special cash dividend of $2.00 per share. The
Third Quarter Net Sales Increased 12.5%, Led by 8.4% Organic Growth; YTD Net Sales Were Up 11.4% with Organic Growth at 7.9% Third Quarter Sand State Sales Increased 21% Driven by Accelerated
ROCKVILLE, MD, Nov. 03, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced the appointments of
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today
AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) — Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of
Follow